ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
151 hedge funds and large institutions have $578M invested in Array Biopharma Inc in 2015 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 45 reducing their positions, and 28 closing their positions.
Holders
151
Holders Change
-6
Holders Change %
-3.82%
% of All Funds
3.97%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
23
Increased
48
Reduced
45
Closed
28
Calls
$6.85M
Puts
$12.2M
Net Calls
-$5.33M
Net Calls Change
-$7.65M
Top Buyers
1 |
1
Millennium Management
New York
|
$21.4M |
2 |
2
Renaissance Technologies
New York
|
$13.5M |
3 |
VAM
3
Visium Asset Management
New York
|
$8.44M |
4 |
OAM
4
Oxford Asset Management
Oxford,
United Kingdom
|
$4.46M |
5 |
TA
5
Teachers Advisors
New York
|
$5.28M |